Sickle Cell Disease Clinical Trials and Phenotypes

gan Ezekekwu, Chinedu A, Kotila, Taiwo R, Akingbola, Titilola S, Lettre, Guillaume, Gordeuk, Victor R, Cooper, Richard S, DeBaun, Michael R, Inusa, Baba, Tayo, Bamidele O
Cyhoeddwyd yn J Trop Dis Public Health (2018)

Fixed Low-Dose Hydroxyurea for the Treatment of Adults with Sickle Cell Anemia in Nigeria

gan Tayo, Bamidele O., Akingbola, Titilola S., Saraf, Santosh L., Shah, Binal N., Ezekekwu, Chinedu A., Sonubi, Omowunmi, Hsu, Lewis L., Cooper, Richard S., Gordeuk, Victor R.
Cyhoeddwyd yn Am J Hematol (2018)

“Maximum Tolerated Dose” versus “Fixed Low-Dose” Hydroxyurea for Treatment of Adults with Sickle Cell Anemia

gan Akingbola, Titilola S., Tayo, Bamidele O., Ezekekwu, Chinedu A., Sonubi, Omowunmi, Zhang, Xu, Saraf, Santosh L., Molokie, Robert, Hsu, Lewis L., Han, Jin, Cooper, Richard S., Gordeuk, Victor R.
Cyhoeddwyd yn Am J Hematol (2019)

Associations of α-thalassemia and BCL11A with stroke in Nigerian, United States, and United Kingdom sickle cell anemia cohorts

gan Saraf, Santosh L., Akingbola, Titilola S., Shah, Binal N., Ezekekwu, Chinedu A., Sonubi, Omowunmi, Zhang, Xu, Hsu, Lewis L., Gladwin, Mark T., Machado, Roberto F., Cooper, Richard S., Gordeuk, Victor R., Tayo, Bamidele O.
Cyhoeddwyd yn Blood Adv (2017)